Infection

, Volume 40, Issue 4, pp 405–413 | Cite as

Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007

  • F. Ladak
  • A. Gjelsvik
  • E. Feller
  • S. Rosenthal
  • B. T. Montague
Clinical and Epidemiological Study

Abstract

Purpose

In the USA, the burden of hepatitis B disproportionately affects high-risk adults who alone account for more than 75% of newly reported hepatitis B virus infections each year. Despite the localization of new infections in identifiable high-risk groups, vaccination rates in this subgroup, with the exception of health care workers, remain consistently low. The purpose of this study was to characterize those at risk for hepatitis B transmission and quantify the association between missed opportunities and hepatitis B vaccination.

Methods

Data from the 2007 Behavioral Risk Factor Surveillance Survey (BRFSS) of adults aged 18 years and older who were at high risk for hepatitis B infection (n = 15,432) were analyzed. Multivariate regression analysis was conducted to determine factors independently associated with vaccination.

Results

In a nationally representative sample, 51.4% of high-risk adults remained unvaccinated against hepatitis B and more than 50% had a missed opportunity for vaccination. High-risk adults who were vaccinated against pneumonia and influenza had a higher odds ratio of being vaccinated against hepatitis B than those not vaccinated against pneumonia and influenza (OR 2.27 and 1.67, respectively). Also, high-risk adults tested for human immunodeficiency virus (HIV) at a counseling and testing site or a drug treatment facility had a higher OR of being vaccinated than those who had not been tested for HIV (OR 1.78 and 1.73, respectively). The opposite relationship was true among individuals tested for HIV at a correctional facility (OR 0.60).

Conclusions

The findings of this study underscore the inadequacy of vaccination coverage in high-risk adults and highlight advantageous opportunities to bridge gaps in vaccination coverage.

Keywords

Hepatitis B virus Vaccination Prevention High-risk adults Missed opportunities 

References

  1. 1.
    Centers for Disease Control and Prevention: Disease burden from viral hepatitis A, B, and C in the United States. Available at:http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden2002.pdf. Accessed 27 Nov 2010.
  2. 2.
    Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. A review of the case for hepatitis B vaccination of high risk adults. Am J Med. 2003;114:316–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations from the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR 2006;55:1–25. http://www.cdc.gov/mmwr/pdf/rr/rr5516.pdf.Google Scholar
  4. 4.
    Wasley A, Moran DK, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192–201.PubMedCrossRefGoogle Scholar
  5. 5.
    Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, Willis B. Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high risk adults. Am J Prev Med. 2005;28:248–79.PubMedCrossRefGoogle Scholar
  6. 6.
    Nidhi J, Yusuf H, Wortley PM, Euler GL, Walton S, Stokley S. Factors associated with receiving the hepatitis B vaccination among high-risk adults in the United States: an analysis of the national health interview survey, 2000. Fam Med. 2004;36:480–6.Google Scholar
  7. 7.
    Mackeller DA, Valleroy LA, Secura GM, et al. Two decades after the vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health. 2001;91:965–71.CrossRefGoogle Scholar
  8. 8.
    Center for Disease Control and Prevention. Achievements in public health: hepatitis B vaccination—United States, 1982–2002. MMWR Morb Mortal Wkl Rep 2002;51:549–53, 563.Google Scholar
  9. 9.
    Centers for Disease Control and Prevention. Hepatitis B vaccination among high-risk adolescents and adults—San Diego, California, 1998–2001. MMWR Morb Mortal Wkl Rep. 2002;51:618–21.Google Scholar
  10. 10.
    IOM (Institute of Medicine). Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. The National Academies Press, Washington, DC; 2010.Google Scholar
  11. 11.
    Centers for Disease Control and Prevention (CDC). Improving influenza, pneumococcal polysaccharide and hepatitis B vaccination coverage among adults <65 years at high risk: a report on recommendations of the task force on community preventative services. MMWR 2005;54(RR-5).Google Scholar
  12. 12.
    Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey questionnaire. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta; 2007.Google Scholar
  13. 13.
    Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey data. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta; 2007.Google Scholar
  14. 14.
    Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis. 2000;181:413–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Infection. 2010;38:269–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Centers for Disease Control and Prevention. Hepatitis B vaccination coverage among adults–United States 2004. MMWR 2006;55:509–511. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a3.htm
  17. 17.
    StataCorp. Stata statistical software: release 10. StatCorp, College Station; 2007.Google Scholar
  18. 18.
    Owens GM. Gender differences in health care expenditure, resource utilization and quality of care. J Manag Care Pharm. 2008;14:S2–6.Google Scholar
  19. 19.
    Joung MA, Vander der Meer JB, Mackenback JP. Marital status and health care utilization. Int J Epidemiol. 1994;24:569–75.CrossRefGoogle Scholar
  20. 20.
    Bevier P, Chamont E, Gallachi MB, Loutan L. Importance of patient’s perceptions and general practitioner’s recommendations in understanding missed opportunities for immunizations in Swiss adults. Vaccine. 2001;19:4760–7.CrossRefGoogle Scholar
  21. 21.
    Orenstein WA, Mootrey GT, Pazol K, Hinman AR. Financing immunization of adults in the United States. Clin Pharmacol Ther. 2007;82:764–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis. 2007;44:1532–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Hepatitis B Foundation. Hepatitis B vaccination. Available at: http://www.hepb.org/hepb/vaccine_information.htm. Accessed 10 May 2010.
  24. 24.
    Rosenbaum S, Stewart A, Cox M, Lee A. Medicaid coverage of immunization in non-institutionalized adults. Center for Health Services Research and Policy, George Washington University, Washington, DC; 2003. Available at: http://www.gwumc.edu/sphhs/departments/healthpolicy/CHPR/downloads/Medicaid_Immunization_Study.pdf. Accessed 27 Feb 2011.
  25. 25.
    Daley MF, Henessey KA, Weinbaum CM, Stockley S, Hurly LP, Crane LA, et al. Physician practices regarding adult hepatitis B vaccination. Am J Prev Med. 2009;36:491–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • F. Ladak
    • 1
    • 6
  • A. Gjelsvik
    • 2
  • E. Feller
    • 3
  • S. Rosenthal
    • 4
  • B. T. Montague
    • 5
  1. 1.Program in Public Health, Division of BiomedicineBrown UniversityProvidenceUSA
  2. 2.Program in Public Health, Center for Population Health and Clinical EpidemiologyBrown UniversityProvidenceUSA
  3. 3.Warren Alpert Medical SchoolBrown UniversityProvidenceUSA
  4. 4.Division of BiomedicineBrown UniversityProvidenceUSA
  5. 5.Infectious DiseasesBrown University/Miriam HospitalProvidenceUSA
  6. 6.BarringtonUSA

Personalised recommendations